NCT02665351View on ClinicalTrials.gov

Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Influenza

Interventions

DRUG

Peramivir

The two regimens of Peramivir were compared

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

Sponsors

Collaborators (1)

BioCryst Pharmaceuticals

All Listed Sponsors

collaborator

BioCryst Pharmaceuticals

INDUSTRY

lead

Chinese University of Hong Kong

OTHER

NCT02665351 - Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections | Biotech Hunter | Biotech Hunter